New hope for eczema in skin of color: dupilumab shows promise

NCT ID NCT05590585

Completed Disease control Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 20 times

Summary

This study looked at how well the drug dupilumab works for people with skin of color who have moderate-to-severe eczema (atopic dermatitis). Eczema causes itchy, dry, cracked skin. The study included 124 adolescents and adults and measured skin improvement after 24 weeks. The goal was to see if dupilumab is safe and effective for this specific group, since most past research focused on lighter skin tones.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Advanced Medical Research PC

Atlanta, Georgia, 30328, United States
Atlanta Biomedical Clinical Research LLC

Atlanta, Georgia, 30331, United States
C2 Research Center, LLC

Montgomery, Alabama, 36117, United States
Callender Dermatology and Cosmetic Center

Glenn Dale, Maryland, 20769, United States
Center for Clinical Studies, LTD.LLP

Houston, Texas, 77004, United States
Center for Dermatology Clinical Research, inc.

Fremont, California, 94538, United States
Century Research LLC

Miami, Florida, 33173, United States
Dermatology and Skin Cancer Specialists, LLC dba US Dermatology Partners

Rockville, Maryland, 20850, United States
Duke University Medical Center

Durham, North Carolina, 27710, United States
Heights Dermatology & Aesthetic Center - Heights Location

Houston, Texas, 77008, United States
Markowitz Medical

New York, New York, 10128, United States
NYC Health + Hospital , Elmhurst Hospital Center

Elmhurst, New York, 11373, United States
National Allergy and Asthma Research, LLC.

North Charleston, South Carolina, 29420, United States
Northwestern Memorial Hospital

Chicago, Illinois, 60611, United States
Oregon Health & Science University

Portland, Oregon, 97239, United States
Philip Fried, MD PLLC

The Bronx, New York, 10463, United States
RFSA Dermatology

San Antonio, Texas, 78213, United States
Rao Dermatology

Atlantic Highlands, New Jersey, 07716, United States
Revival Research Institute , LLC

Troy, Michigan, 48084, United States
SF Research Institute

San Francisco, California, 94127, United States
SUNY Downstate Medical Center

Brooklyn, New York, 11203, United States
Skin and Cancer Associates, LLP

Miami, Florida, 33137, United States
Texas Dermatology and Laser Specialists

San Antonio, Texas, 78218, United States
The University Of Alabama At Birmingham

Birmingham, Alabama, 35233, United States
Total Skin & Beauty Dermatology Center

Birmingham, Alabama, 35203, United States
UCSD/ Rady Children's Hospital

San Diego, California, 92123, United States
UCSF

San Francisco, California, 94118, United States
University of Miami Miller School of Medicine

Miami, Florida, 33136, United States
Washington University School of Medicine

St Louis, Missouri, 63110, United States
Wayne State University Physician Group Dermatology

Dearborn, Michigan, 48126, United States

Conditions

Explore the condition pages connected to this study.

ATOPIC ECZEMA MODERATE-TO-SEVERE ATOPIC DERMATITIS